Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 10.0B | 9.3B | 8.7B | 10.1B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 3.1B | 3.6B | 3.0B | 3.1B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 4.3B | 3.8B | 3.9B | 4.3B |
| Tax provision | 1.5B | 1.2B | 1.1B | 1.4B |
| Net income | 2.9B | 2.6B | 2.7B | 2.9B |
| Basic EPS | 0.5 | 0.4 | 0.4 | 0.5 |
| Diluted EPS | 0.5 | 0.4 | 0.4 | 0.5 |
| Basic average shares | 6.0B | 6.1B | 6.0B | 5.9B |
| Diluted average shares | 6.0B | 6.1B | 6.0B | 5.9B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 2.9B | — | — | 2.9B |
| Minority interests | -184M | -155M | -105M | -154M |
| Preferred stock dividends | — | — | — | — |